Announcements Trials
Browse Landscape

Phase

Phase NA 3Phase 1 3Phase 3 1Phase 2 1

Status

Completed 3Recruiting 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Conditions

Neoplasms 1331Breast Neoplasms 688Carcinoma, Non-Small-Cell Lung 543Neoplasm Metastasis 437Lymphoma 435Leukemia, Myeloid, Acute 432Melanoma 402Prostatic Neoplasms 380Multiple Myeloma 366Lymphoma, Non-Hodgkin 356Ovarian Neoplasms 343Colorectal Neoplasms 333Precursor Cell Lymphoblastic Leukemia-Lymphoma 328Pancreatic Neoplasms 328Leukemia, Lymphocytic, Chronic, B-Cell 323Leukemia 282Lung Neoplasms 275Glioblastoma 267Unspecified Adult Solid Tumor, Protocol Specific 257Recurrence 254Lymphoma, Follicular 248Lymphoma, Large B-Cell, Diffuse 245Brain Neoplasms 232Lymphoma, Mantle-Cell 210Hodgkin Disease 193Carcinoma, Renal Cell 193Head and Neck Neoplasms 192Myelodysplastic Syndromes 187Glioma 172Burkitt Lymphoma 172

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 1 × Completed × Parkinson Disease × Clear all
NCT01691924 2016-03-08

Study To Assess the Safety and Tolerability of PBF-509 in Male Healthy Volunteers

Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau

Phase 1 Completed
56 enrolled

Neoplasms, Parkinson Disease

NCT02111330 2016-03-08

Study to Assess the Safety, Tolerability and Pharmacokinetic Profile of PBF -509 (80 mg, 160 mg and 240 mg) "After Multiple Oral Doses" in Healthy Volunteers

Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau

Phase 1 Completed
16 enrolled

Neoplasms, Parkinson Disease

NCT01698450 2014-10-09

Magnetic Resonance (MR) Guided Functional Ultrasound-Neurosurgery for Movement Disorders

University Children's Hospital, Zurich

Phase 1 Completed
10 enrolled

Dystonia, Movement Disorders, Neuralgia, Parkinson Disease, Essential Tremor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡